Safinamide tatoside A CN(CC1=CC=CC=C1N(CCO)S(=O)(=O)C1C=CC(=CC=1)OC)C/C=C/C1C=CC(Cl)=CC=1

CN(CC1=CC=CC=C1N(CCO)S(=O)(=O)C1C=CC(=CC=1)OC)C/C=C/C1C=CC(Cl)=CC=1

TAK-779 did not affect production of IL-12 by antigen-presenting cells

reparixin alone or in combination with docetaxel reduced tumor growth compared with saline control

and has been shown to improve mitochondrial function and to confer significant cellular protection in neurons under stress

Smiles: CC1(C)C=CC2=CC(CCN3C4=CC=CC=C4C4=CC=CC=C34)=CC(C=O)=C2O1

Safinamide tatoside A CN(CC1=CC=CC=C1N(CCO)S(=O)(=O)C1C=CC(=CC=1)OC)C/C=C/C1C=CC(Cl)=CC=1Safinamide, also known as FCE 26743 and EMD 1195686, is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless legs syndrome (RLS) and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducing degradation of dopamine, and a glutamate release inhibitor. It also inhibits dopamine reuptake. Additionally, safinamide blocks sodium and calcium